FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine, namely to cardiology, and concerns the endothelial dysfunction correction. That is ensured by a therapeutic agent containing an activated potentiating form of vascular endothelium growth factor (VEGF) antibodies. The activity of the therapeutic agent is related to the process of multiple serial dilutions in an aqueous or aqueous-alcohol solution in a combination with an external mechanical vertical agitation of each dilution.
EFFECT: method provides the effective L-NAME-induced endothelial dysfunction correction in experiment.
6 cl, 1 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR CORRECTION OF ENDOTHELIAL DYSFUNCTION | 2011 |
|
RU2526149C2 |
| MEDICATION FOR CORRECTION OF ENDOTHELIAL DYSFUNCTION | 2011 |
|
RU2536228C2 |
| THERAPEUTIC AGENT FOR ENDOTHELIAL DYSFUNCTION CORRECTION | 2011 |
|
RU2543331C2 |
| THERAPEUTIC AGENT FOR ENDOTHELIAL DYSFUNCTION CORRECTION | 2011 |
|
RU2543332C2 |
| METHOD FOR ENDOTHELIAL DYSFUNCTION CORRECTION | 2011 |
|
RU2542403C2 |
| METHOD FOR ENDOTHELIAL DYSFUNCTION CORRECTION | 2011 |
|
RU2541166C2 |
| METHOD FOR CORRECTION OF ENDOTHELIAL DYSFUNCTION | 2011 |
|
RU2527689C2 |
| METHOD OF TREATING CHRONIC CARDIAC FAILURE AND PHARMACEUTICAL COMPOSITION FOR TREATING CHRONIC CARDIAC FAILURE | 2011 |
|
RU2523451C2 |
| METHOD OF INCREASING THE PHARMACOLOGICAL ACTIVITY OF THE ACTIVATED-POTENTIATED FORM OF ANTIBODIES TO THE PROSTATE-SPECIFIC ANTIGEN AND THE PHARMACEUTICAL COMPOSITION | 2014 |
|
RU2651005C2 |
| METHOD FOR INCREASING PHARMACOLOGICAL ACTIVITY OF ACTIVE SUBSTANCE OF MEDICINAL PRODUCT AND PHARMACEUTICAL COMPOSITION | 2014 |
|
RU2572706C1 |
